Single infusion of donor early apoptotic cells (ApoCell) as prophylaxis of graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation

被引:0
|
作者
Mevorach, D. [1 ]
Reiner, I. [1 ]
Zuckerman, T. [2 ]
Shimoni, A. [3 ]
Nagler, A. [3 ]
Rowe, J. [4 ]
Or, R. [1 ]
机构
[1] Hadassah Hebrew Univ, Jerusalem, Israel
[2] Rambam, Haifa, Israel
[3] Tel Hashomer, Tel Aviv, Israel
[4] Sharey Zedek, Jerusalem, Israel
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S172 / S172
页数:1
相关论文
共 50 条
  • [1] Single-Infusion of Donor Early Apoptotic Cells (ApoCell) As Prophylaxis of Graft-Versus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantati
    Mevorach, Dror
    Reiner, Inna
    Or, Reuven
    [J]. BLOOD, 2012, 120 (21)
  • [2] Single Infusion of Donor Mononuclear Early Apoptotic Cells as Prophylaxis for Graft-versus-Host Disease in Myeloablative HIA-Matched Allogeneic Bone Marrow Transplantation: A Phase I/IIa Clinical Trial
    Mevorach, Dror
    Zuckerman, Tsila
    Reiner, Inna
    Shimoni, Avichai
    Samuel, Simcha
    Nagler, Arnon
    Rowe, Jacob M.
    Or, Reuven
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (01) : 58 - 65
  • [3] Early Apoptotic Cells (ApoCell) As Prophylaxis of GraftVersus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantation Is Safe and Effective: 1 Year Follow-up
    Mevorach, Dror
    Tzila, Zuckerman
    Nagler, Arnon
    Rowe, Jacob M.
    Or, Reuven
    [J]. BLOOD, 2014, 124 (21)
  • [4] EARLY APOPTOTIC CELLS AS PROPHYLAXIS OF GRAFT VERSUS-HOST DISEASE IN. MYELOABLATIVE HLA-MATCHED ALLOGENEIC BONE MARROW TRANSPLANTATION IS SAFE AND EFFECTIVE: 1 YEAR FOLLOW-UP AND BIOMARKER PROFILE
    Mevorach, D.
    Tabib, A.
    [J]. CYTOTHERAPY, 2016, 18 (06) : S23 - S23
  • [5] Post-Transplantation Cyclophosphamide Versus Tacrolimus and Methotrexate Graft-Versus-Host Disease Prophylaxis for HLA-Matched Donor Transplantation
    Mehta, Rohtesh S.
    Saliba, Rima M.
    Rondon, Gabriela
    Al-Atrash, Gheath
    Bashir, Qaiser
    Hosing, Chitra M.
    Kebriaei, Partow
    Khouri, Issa
    Nieto, Yago
    Oran, Betul
    Popat, Uday R.
    Qazilbash, Muzaffar H.
    Ramdial, Jeremy
    Srour, Samer A.
    Champlin, Richard E.
    Rezvani, Katayoun
    Shpall, Elizabeth J.
    Alousi, Amin M.
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (10): : 695.e1 - 695.e10
  • [6] DONOR ALLOREACTIVITY MAY PREDICT ACUTE GRAFT-VERSUS-HOST DISEASE IN HLA-MATCHED BONE-MARROW TRANSPLANTATION FOR LEUKEMIA IN EARLY REMISSION
    JOHNSEN, HE
    BEATTY, PG
    MICHELSON, E
    HANSEN, JA
    THOMAS, ED
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1992, 48 (05) : 249 - 253
  • [7] TRANSFUSION EFFECT ON GRAFT-VERSUS-HOST DISEASE AND LEUKEMIC RELAPSE IN HLA-MATCHED BONE-MARROW TRANSPLANTATION
    DEGAST, GC
    BEATTY, PG
    AMOS, D
    SULLIVAN, K
    ANDERSON, JE
    THOMAS, ED
    HANSEN, JA
    [J]. TRANSPLANTATION PROCEEDINGS, 1987, 19 (01) : 2700 - 2700
  • [8] Are the functional assays useful in predicting graft-versus-host disease in HLA-matched sibling bone marrow transplantation?
    Dickinson, A
    Wang, XN
    [J]. TRANSPLANTATION, 2001, 72 (06) : 1168 - 1168
  • [9] Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation
    PG Middleton
    H Cullup
    AM Dickinson
    J Norden
    GH Jackson
    PRA Taylor
    J Cavet
    [J]. Bone Marrow Transplantation, 2002, 30 : 223 - 228
  • [10] Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation
    Middleton, PG
    Cullup, H
    Dickinson, AM
    Norden, J
    Jackson, GH
    Taylor, PRA
    Cavet, J
    [J]. BONE MARROW TRANSPLANTATION, 2002, 30 (04) : 223 - 228